Overview

Teneligliptin-Glimepiride DDI Study

Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
An open label, one sequence study to investigate the pharmacokinetic drug interaction between Teneligliptin and Glimepiride in healthy male subjects
Phase:
Phase 1
Details
Lead Sponsor:
Handok Inc.
Handok Pharmaceuticals Co., Ltd.
Treatments:
Glimepiride